Digital Health Vital Signs Monitoring Platforms sector
Strategic acquirers, private equity (buyout funds and growth funds) firms, and valuation benchmarks for Digital Health Vital Signs Monitoring Platforms
1.1 - About Digital Health Vital Signs Monitoring Platforms sector
Companies in the Digital Health Vital Signs Monitoring Platforms category provide connected patient monitoring solutions that capture and stream multi‑parameter vitals—heart rate, SpO2, blood pressure, temperature, and respiration—across hospital, home, and ambulatory settings. Often viewed as strategic buyers in vital signs monitoring and remote patient monitoring, they deliver continuous data collection, clinical visibility, and timely alerts, backed by interoperable, HIPAA‑compliant cloud infrastructure to improve care quality, workflow efficiency, and scalability.
Typical offerings include remote patient monitoring platforms paired with wearable biosensors and multi‑parameter bedside monitors. Vendors provide patient mobile apps, clinician dashboards for triage and escalation, rules‑based and AI‑driven alerting, and EHR interoperability via HL7/FHIR APIs. They enable device connectivity and fleet management, secure data ingestion and normalization, care plan automation, documentation and billing support for RPM codes, and analytics that stratify risk, track trends, and surface deterioration early.
Primary customers include hospitals and health systems, telehealth providers and virtual care programs, and home health organizations. Outcomes commonly achieved are earlier detection of clinical deterioration, reduced readmissions and avoidable ED visits, improved care coordination across sites of service, and stronger reimbursement capture for RPM programs. Buyers also benefit from streamlined clinical workflows, better patient engagement, and enterprise‑grade data governance that supports scalability and regulatory compliance.
2. Buyers in the Digital Health Vital Signs Monitoring Platforms sector
2.1 Top strategic acquirers of Digital Health Vital Signs Monitoring Platforms companies
Owlet
- Description: Provider of modern parenting technology offering the first FDA-cleared smart baby monitor and a connected nursery ecosystem that delivers trusted health insights when parents need them most.
- Key Products:
- Smart Baby Monitor & Connected Nursery Ecosystem: FDA-cleared monitor integrated with nursery ecosystem, providing real-time trusted health insights to parents for safer, more informed caregiving
- BabySat FDA-Cleared Baby Monitor: Stand-alone FDA-cleared baby monitor designed to track infants’ health status, giving parents confidence through compliant, reliable monitoring technology.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
2.2 - Strategic buyer groups for Digital Health Vital Signs Monitoring Platforms sector
M&A buyer group 1: Remote Patient Monitoring
Huma
- Type: N/A
- Employees: ●●●●●
- Description: Provider of AI-driven digital health solutions that include a cloud platform for rapidly building regulated health apps, remote patient monitoring, virtual wards and clinical trial tools, plus AI modules that automate documentation, triage and care workflows to optimise patient outcomes.
- Key Products:
- Huma Cloud Platform: Highly configurable, flexible, disease-agnostic cloud infrastructure offering code-free configuration, multi-device connectivity and hosting of AI/ML models with multiple regulatory clearances for rapid digital health solution deployment
- Remote Patient Monitoring Programmes: Programmes capture real-world health data, enable continuous remote monitoring and self-management, empowering proactive, preventative care while reducing hospital burden
- Companion Apps: Mobile companion applications integrate with the platform to support online or face-to-face consultations, deliver personalised insights and guide patients through their health journeys
- Risk Assessment Tools & AI Algorithms: AI-powered, including generative AI, algorithms analyse patient histories to generate personalised risk assessments, predictive insights and optimise treatment outcomes for clinicians and researchers.
Buyer group 2: ████████ ████████
●● companiesBuyer group 3: ████████ ████████
●● companies3. Investors and private equity firms in Digital Health Vital Signs Monitoring Platforms sector
3.1 - Buyout funds in the Digital Health Vital Signs Monitoring Platforms sector
2.2 - Strategic buyer groups for Digital Health Vital Signs Monitoring Platforms sector
4 - Top valuation comps for Digital Health Vital Signs Monitoring Platforms companies
4.2 - Public trading comparable groups for Digital Health Vital Signs Monitoring Platforms sector
Valuation benchmark group 1: Medical Monitoring and Respiratory Device Companies
ResMed
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of cloud-connectable medical devices and digital health technologies aimed at diagnosing, treating, and managing sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory disorders, thereby enhancing patient health and quality of life.
- Key Products:
- CPAP Devices: Cloud-connectable CPAP machines for sleep apnea treatment
- CPAP Masks: Comfortable and effective masks for CPAP therapy
- Respiratory Care Devices: Ventilators and bilevel devices for respiratory support
- Digital Health Solutions: Software platforms for managing respiratory conditions
- Accessories: Tubing, humidifiers, and other CPAP accessories for enhanced therapy